84 related articles for article (PubMed ID: 17420124)
1. Concise synthesis of dideoxy-epigallocatechin gallate (DO-EGCG) and evaluation of its anti-influenza virus activity.
Furuta T; Hirooka Y; Abe A; Sugata Y; Ueda M; Murakami K; Suzuki T; Tanaka K; Kan T
Bioorg Med Chem Lett; 2007 Jun; 17(11):3095-8. PubMed ID: 17420124
[TBL] [Abstract][Full Text] [Related]
2. Enhanced anti-influenza A virus activity of (-)-epigallocatechin-3-O-gallate fatty acid monoester derivatives: effect of alkyl chain length.
Mori S; Miyake S; Kobe T; Nakaya T; Fuller SD; Kato N; Kaihatsu K
Bioorg Med Chem Lett; 2008 Jul; 18(14):4249-52. PubMed ID: 18547804
[TBL] [Abstract][Full Text] [Related]
3. [Antiviral effect of epigallocatechin gallate (EGCG) on influenza A virus].
Xiao X; Yang ZQ; Shi LQ; Liu J; Chen W
Zhongguo Zhong Yao Za Zhi; 2008 Nov; 33(22):2678-82. PubMed ID: 19216171
[TBL] [Abstract][Full Text] [Related]
4. Identification of two biologically crucial hydroxyl groups of (-)-epigallocatechin gallate in osteoclast culture.
Nakagawa H; Hasumi K; Takami M; Aida-Hyugaji S; Woo JT; Nagai K; Ishikawa T; Wachi M
Biochem Pharmacol; 2007 Jan; 73(1):34-43. PubMed ID: 17034764
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel bisheterocycle-containing compounds as potential anti-influenza virus agents.
Wang WL; Yao DY; Gu M; Fan MZ; Li JY; Xing YC; Nan FJ
Bioorg Med Chem Lett; 2005 Dec; 15(23):5284-7. PubMed ID: 16183283
[TBL] [Abstract][Full Text] [Related]
6. Relationship between the biological activities of methylated derivatives of (-)-epigallocatechin-3-O-gallate (EGCG) and their cell surface binding activities.
Yano S; Fujimura Y; Umeda D; Miyase T; Yamada K; Tachibana H
J Agric Food Chem; 2007 Aug; 55(17):7144-8. PubMed ID: 17661493
[TBL] [Abstract][Full Text] [Related]
7. Biological evaluation of anti-influenza viral activity of semi-synthetic catechin derivatives.
Song JM; Park KD; Lee KH; Byun YH; Park JH; Kim SH; Kim JH; Seong BL
Antiviral Res; 2007 Nov; 76(2):178-85. PubMed ID: 17709148
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of influenza virus internalization by (-)-epigallocatechin-3-gallate.
Kim M; Kim SY; Lee HW; Shin JS; Kim P; Jung YS; Jeong HS; Hyun JK; Lee CK
Antiviral Res; 2013 Nov; 100(2):460-72. PubMed ID: 23954192
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en.
Honda T; Kubo S; Masuda T; Arai M; Kobayashi Y; Yamashita M
Bioorg Med Chem Lett; 2009 Jun; 19(11):2938-40. PubMed ID: 19414262
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity studies of (-)-epigallocatechin gallate derivatives as HCV entry inhibitors.
Bhat R; Adam AT; Lee JJ; Deloison G; Rouillé Y; Séron K; Rotella DP
Bioorg Med Chem Lett; 2014 Sep; 24(17):4162-5. PubMed ID: 25103601
[TBL] [Abstract][Full Text] [Related]
11. Epigallocatechin gallate inhibits intracellular survival of Listeria monocytogenes in macrophages.
Kohda C; Yanagawa Y; Shimamura T
Biochem Biophys Res Commun; 2008 Jan; 365(2):310-5. PubMed ID: 17996193
[TBL] [Abstract][Full Text] [Related]
12. Antiviral effect of epigallocatechin gallate on enterovirus 71.
Ho HY; Cheng ML; Weng SF; Leu YL; Chiu DT
J Agric Food Chem; 2009 Jul; 57(14):6140-7. PubMed ID: 19537794
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anti-influenza virus activity of dihydrofuran-fused perhydrophenanthrenes with a benzyloxy-type side-chain.
Matsuya Y; Suzuki N; Kobayashi SY; Miyahara T; Ochiai H; Nemoto H
Bioorg Med Chem; 2010 Feb; 18(4):1477-81. PubMed ID: 20097080
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of antibacterial effects of epigallocatechin gallate, using ascorbic acid.
Hatano T; Tsugawa M; Kusuda M; Taniguchi S; Yoshida T; Shiota S; Tsuchiya T
Phytochemistry; 2008 Dec; 69(18):3111-6. PubMed ID: 17889045
[TBL] [Abstract][Full Text] [Related]
15. Time-dependent intracellular trafficking of FITC-conjugated epigallocatechin-3-O-gallate in L-929 cells.
Han DW; Matsumura K; Kim B; Hyon SH
Bioorg Med Chem; 2008 Nov; 16(22):9652-9. PubMed ID: 18951028
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of epigallocatechin gallate (EGCG) combined with zinc sulfate and silver nanoparticles on avian influenza A virus subtype H5N1.
Saadh MJ; Aldalaen SM
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2630-2636. PubMed ID: 33829450
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
[TBL] [Abstract][Full Text] [Related]
18. Covalent modification of proteins by green tea polyphenol (-)-epigallocatechin-3-gallate through autoxidation.
Ishii T; Mori T; Tanaka T; Mizuno D; Yamaji R; Kumazawa S; Nakayama T; Akagawa M
Free Radic Biol Med; 2008 Nov; 45(10):1384-94. PubMed ID: 18771724
[TBL] [Abstract][Full Text] [Related]
19. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
Hudson SA; Ecroyd H; Dehle FC; Musgrave IF; Carver JA
J Mol Biol; 2009 Sep; 392(3):689-700. PubMed ID: 19616561
[TBL] [Abstract][Full Text] [Related]
20. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
